Healthleap raises $38M to expand its hospital screening software
Siblings Jemima and Josiah Meyer turned a dietitian's tool into a broader EHR screening platform. The financing combines an $8M seed with a $30M Series A.
By RuntimeWire Staff · Published
Primary source: TechCrunch
Why it matters
Healthleap is turning a clinician-built nutrition tool into a broader EHR screening layer. Its malnutrition results and hospital deployments support the initial market case, while newer condition programs still need clinical validation.
Dietitian Jemima Meyer and her brother, Healthleap CEO Josiah Meyer, raised $38 million to expand software that scans hospital records for patients whose conditions may have been missed. The financing, reported by TechCrunch, combines an $8 million seed round co-led by Sequoia Capital and First Round Capital with a $30 million Series A led by Hummingbird Ventures. Healthleap did not disclose its valuation.
Healthleap grew out of Jemima Meyer's work as a clinical dietitian. She built NutriLeap, an early tool to help dietitians find and treat patients sooner, after seeing patients' nutritional needs go unnoticed in understaffed hospital workflows. She brought in Josiah, her brother and a serial entrepreneur who Healthleap says has been building businesses since his teens, to take that clinical problem beyond what one dietitian could reach. Healthleap's account of its founding describes the effort as building a safety net for patients who might otherwise be missed.
That origin still shapes the product's expansion. Healthleap began with malnutrition screening, where it could compare its results against dietitian assessments and discharge records. Healthleap says the platform is now deployed in more than 50 hospitals, up from three hospital partners a year earlier, and screens for malnutrition and delirium. Programs for aspiration pneumonia, pressure injuries and congestive heart failure readmission risk are undergoing further clinical validation, according to Josiah's comments to TechCrunch.
From a dietitian's tool to a daily hospital screen
Healthleap connects to a hospital's electronic health record and reviews each adult inpatient's chart overnight. It combines structured information such as lab results, vital signs, medications and diagnoses with details in clinician notes, including references to poor appetite, weight loss or trouble swallowing. Language models extract those concepts; risk models then use them to identify patients for clinical review. Each morning, a score appears in the care team's existing workflow.
Josiah told TechCrunch that charts contain signals in both structured fields and clinicians' written notes. The software brings those signals together and flags patients who may merit attention. It does not diagnose them or replace clinicians' judgment.
The strongest published evidence is for malnutrition screening. The Applied Clinical Informatics study analyzed 166,841 hospital admissions involving 106,449 patients, collected from January 1st, 2019, through September 14th, 2022, a period described as nearly 3.75 years. It reported an AUROC of 0.92 on the first hospital day and 0.95 using the highest predicted risk during an admission. Against dietitian-recorded malnutrition, sensitivity was 0.52 for the model and 0.35 for the modified Malnutrition Screening Tool; against discharge-coded malnutrition, the figures were 0.49 and 0.24. The model flagged malnutrition earlier than the first dietitian documentation in 72.7% of cases, with a median lead time of 1.3 days and a mean of 4.0 days. These results concern malnutrition screening and do not establish performance for the newer condition programs.
Hospitals are the buyer, and the outcome is part of the pitch
Healthleap's sales case centers on fitting into hospital routines and demonstrating financial returns. Healthleap sells three-year contracts priced by licensed bed count and also offers outcome-based pricing, Josiah told TechCrunch. He said revenue grew more than 10 times year over year, without disclosing the revenue base. Healthleap plans to use the new funding for engineering, product, sales and customer success as it adds more conditions.
Healthleap says its work at the Hospital of the University of Pennsylvania generated $23.8 million in annualized financial impact, including $6.3 million in additional reimbursement and $17.5 million attributed to shorter stays. A Healthleap case study, updated in August 2026, says Penn Medicine's Strategic Decision Support team validated the financial figures. Healthleap also reports $11 million in annual impact at Cedars-Sinai. These are deployment outcomes presented by Healthleap; they are not evidence that each hospital will see the same result.
The $38 million round follows a $1.1 million pre-seed financing led by Fifty Years in January 2022, when the product was centered on supporting dietitians with nutrition calculations and clinical recommendations. Whether that earlier pre-seed is included in the newly reported $38 million total is not specified. The shift from a specialized dietitian's tool to a broader inpatient screening platform gives the new capital a clear job: build and validate additional clinical programs while selling into hospital systems that need evidence of both clinical usefulness and operational return.